Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

NCT05848687 is registered in ClinicalTrials.gov with Tanja Andrea Gruber as lead sponsor.

NCT NCT05848687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05848687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Lead sponsor
Tanja Andrea Gruber
Phase
Phase 1/2
Overall status
Recruiting
Start date
November 3, 2023
Completion date
December 31, 2033
Enrollment
90 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoblastic leukemia